Form 4: Labcorp Director Kerrii B. Anderson Sells 1,000 Shares Under 10b5-1 Plan

Kerrii B. Anderson, a director at Labcorp Holdings Inc., sold 1,000 shares of common stock at $230 per share on October 24, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On October 24, 2024, Kerrii B. Anderson, a director of Labcorp Holdings Inc. [LH], sold 1,000 shares of the company's common stock.
• The sale was executed at a price of $230 per share.
• The transaction was conducted under a pre-arranged trading plan in accordance with Rule 10b5-1.
• Following the transaction, Anderson directly owns 13,722 shares of Labcorp common stock.
• Anderson also indirectly owns shares through separate trusts for Alexa M. Anderson and Cameron Taff Anderson.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale, but the 10b5-1 plan mitigates concerns about insider information.

Key Dates